CVS Health Co. (NYSE:CVS) Stock Position Lessened by Logan Capital Management Inc.

Logan Capital Management Inc. decreased its holdings in CVS Health Co. (NYSE:CVSGet Rating) by 5.2% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 15,013 shares of the pharmacy operator’s stock after selling 817 shares during the quarter. Logan Capital Management Inc.’s holdings in CVS Health were worth $1,520,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Arlington Partners LLC boosted its stake in CVS Health by 23.4% during the first quarter. Arlington Partners LLC now owns 528 shares of the pharmacy operator’s stock valued at $53,000 after buying an additional 100 shares in the last quarter. Wiley BROS. Aintree Capital LLC boosted its stake in CVS Health by 4.6% during the first quarter. Wiley BROS. Aintree Capital LLC now owns 2,265 shares of the pharmacy operator’s stock valued at $229,000 after buying an additional 100 shares in the last quarter. Palladium Partners LLC lifted its holdings in shares of CVS Health by 2.8% during the first quarter. Palladium Partners LLC now owns 3,687 shares of the pharmacy operator’s stock valued at $373,000 after purchasing an additional 100 shares during the last quarter. Tortoise Investment Management LLC lifted its holdings in shares of CVS Health by 6.6% during the first quarter. Tortoise Investment Management LLC now owns 1,612 shares of the pharmacy operator’s stock valued at $163,000 after purchasing an additional 100 shares during the last quarter. Finally, Keudell Morrison Wealth Management lifted its holdings in shares of CVS Health by 3.2% during the first quarter. Keudell Morrison Wealth Management now owns 3,266 shares of the pharmacy operator’s stock valued at $331,000 after purchasing an additional 102 shares during the last quarter. Institutional investors own 77.64% of the company’s stock.

CVS Health Stock Performance

CVS opened at $102.15 on Monday. The firm has a market capitalization of $134.11 billion, a P/E ratio of 16.61, a price-to-earnings-growth ratio of 1.55 and a beta of 0.73. The stock’s 50 day moving average price is $98.77 and its two-hundred day moving average price is $99.39. The company has a quick ratio of 0.65, a current ratio of 0.91 and a debt-to-equity ratio of 0.67. CVS Health Co. has a 12-month low of $81.78 and a 12-month high of $111.25.

CVS Health (NYSE:CVSGet Rating) last released its earnings results on Wednesday, August 3rd. The pharmacy operator reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.16 by $0.24. The firm had revenue of $80.64 billion for the quarter, compared to analyst estimates of $76.38 billion. CVS Health had a return on equity of 15.19% and a net margin of 2.65%. The company’s revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the firm posted $2.42 EPS. On average, equities analysts forecast that CVS Health Co. will post 8.54 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 1st. Stockholders of record on Friday, July 22nd were issued a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a dividend yield of 2.15%. The ex-dividend date was Thursday, July 21st. CVS Health’s payout ratio is presently 35.77%.

Insider Transactions at CVS Health

In related news, EVP Alan Lotvin sold 22,541 shares of the firm’s stock in a transaction that occurred on Thursday, August 4th. The stock was sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the completion of the transaction, the executive vice president now owns 109,183 shares in the company, valued at approximately $11,355,032. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, EVP Thomas M. Moriarty sold 138,654 shares of the firm’s stock in a transaction that occurred on Tuesday, June 28th. The stock was sold at an average price of $95.00, for a total transaction of $13,172,130.00. Following the completion of the transaction, the executive vice president now owns 626,273 shares in the company, valued at approximately $59,495,935. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Alan Lotvin sold 22,541 shares of the firm’s stock in a transaction that occurred on Thursday, August 4th. The stock was sold at an average price of $104.00, for a total value of $2,344,264.00. Following the transaction, the executive vice president now owns 109,183 shares of the company’s stock, valued at approximately $11,355,032. The disclosure for this sale can be found here. 0.69% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CVS. Credit Suisse Group upped their target price on CVS Health from $113.00 to $117.00 and gave the company an “outperform” rating in a report on Monday, August 8th. UBS Group upped their target price on CVS Health from $118.00 to $127.00 and gave the company a “buy” rating in a report on Thursday, August 4th. Tigress Financial increased their price objective on CVS Health from $125.00 to $130.00 in a research note on Wednesday, August 17th. Deutsche Bank Aktiengesellschaft increased their price objective on CVS Health from $113.00 to $120.00 in a research note on Thursday, August 4th. Finally, Loop Capital began coverage on CVS Health in a research note on Thursday, June 16th. They issued a “buy” rating and a $120.00 price objective for the company. Four analysts have rated the stock with a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and an average price target of $117.59.

CVS Health Profile

(Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Read More

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.